X
X
Tired?
Unfocused?
Off your game?

Read our free Dr K report on how to optimize your mind and body so you can boost your focus when trading the markets.
YES, SEND ME THE REPORT !
NO, I'M NOT INTERESTED
Your email will always remain private.

VoSI VooDoo(TM) Report - July 8, 2017

The VoSI VooDoo Report

Offbeat Ideas and Commentary from the Depths of Gil's Trading Notes

Some of the better patterns holding up in this market are biotechs and medicals. I've put together a screened list of bio-techs and medical names below. They are sorted by HGS Investor ERG Rating, which is comparable to O'Neil's Composite Rating.

We can see a familiar name, Glaukos (GKOS) on the list. It is back above its 50-dma as it tries to round out the right side of a potential new base. One that looks similar is Incyte Pharmaceuticals (INCY) which has also regained its 50-dma as it too attempts to round out what may be the right side of a new base. Here's INCY's chart:

Both GKOS and INCY represent chart patterns in search of a concrete buy signal, although for now it appears that only low-volume pullbacks into the 50-dma or perhaps the 20-dema represent buyable moves. Vertex Pharmaceuticals (VRTX) and Bioverativ (BIVV) are also on the list, and both are pulling back into areas of support after recent breakouts. Here's the daily chart of BIVV, which is a recent IPO that was a spin-off of Biogen's Global Hemophilia business:

And then there are the big-stock names in the "bio-med" space like Biogen Idec (BIIB), Celgene (CELG), Alexion Pharmaceuticals (ALXN), Baxter (BAX), and Regeneron Pharmaceuticals (REGN). Most of these can be found in the iShares NASDAQ Biotech ETF (IBB), which is forming a flag formation here after jacking to the upside in mid-June. Among these bigger bio-techs, BIIB looks interesting here, as does BAX.

And then there are the tiny bio-techs like Corcept Therapeutics (CORT) and Lantheus Holdings (LNTH). Exact Sciences (EXAS), which makes the new "get, go, gone" colon cancer test you see advertised on TV, is also an interesting situation. I would suggest going through each of the stocks on this list I've posted at the top of this VooDoo Report and investigating each more thoroughly. I intend to continue monitoring this list as an area of interest where I hope to find concrete buy points show up in real-time. If I see something actionable, it will likely be mentioned in a real-time VooDoo Report or the usual Pocket Pivot or Buyable Gap-Up Reports, depending on the specific set-up.



This information is provided by MoKa Investors, LLC DBA Virtue of Selfish Investing (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2018 MoKa Investors, LLC DBA Virtue of Selfish Investing. All rights reserved.
FOR OUR FREE MARKET LAB REPORT :
Copyright ©2018 MoKa Investors, LLC DBA Virtue of Selfish Investing.
All Rights Reserved.
privacy policy